Exercise Decreases Anti-Mullerian Hormone in Anovulatory Overweight Women with Polycystic Ovary Syndrome - A Pilot Study

被引:33
|
作者
Moran, L. J. [1 ]
Harrison, C. L. [1 ]
Hutchison, S. K. [1 ,2 ]
Stepto, N. K. [3 ]
Strauss, B. J. [4 ,5 ,6 ]
Teede, H. J. [1 ,2 ]
机构
[1] Monash Univ, Jean Hailes Fdn Womens Hlth Res Unit, Sch Publ Hlth & Prevent Med, Clayton, Vic, Australia
[2] So Hlth, Diabet Unit, Clayton, Vic, Australia
[3] Victoria Univ, Inst Sport Exercise & Act Living, Clayton, Vic, Australia
[4] Monash Univ, Dept Med, Clayton, Vic, Australia
[5] Monash Univ, Dept Nutr, Clayton, Vic, Australia
[6] Monash Univ, Dept Dietet, Clayton, Vic, Australia
关键词
REPRODUCTIVE AGE; OBESE WOMEN; WEIGHT-LOSS;
D O I
10.1055/s-0031-1291208
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Polycystic ovary syndrome (PCOS) is a common condition in women associated with menstrual irregularity and anovulation. While obesity worsens and weight loss or exercise improves reproduction function in PCOS, the mechanism for this is unclear. The aim of this study was to examine the effect of exercise on ovarian hormones [anti-Mullerian hormone (AMH)] and menstrual and ovulatory function in women with and without PCOS. Overweight women with (n = 7) and without (n = 8) PCOS of comparable age, weight and BMI undertook a 12-week intensified endurance exercise training program (1 h 3 times/week) with no structured energy restriction. Primary outcomes were AMH, ovulation (weekly urinary pregnanediol) and menstrual regularity. Secondary outcomes were insulin resistance (euglycemic hyperinsulinemic clamp) and body composition (computed tomography and dual X-ray absorptiometry). Exercise decreased BMI, total and android fat mass and improved insulin sensitivity for all women. AMH was significantly higher in women with PCOS compared to controls before (p < 0.001) and after exercise (p = 0.001). There was a significant interaction between AMH changes with exercise and PCOS status (p = 0.007) such that women without PCOS had no change in AMH (+1.4 +/- 5.2 pmol/l, p = 0.48) while women with PCOS had a decrease in AMH (-13.2 +/- 11.7 pmol/l, p = 0.025). Exercise is associated with improvements in ovarian hormones in women with abnormal ovarian function. This suggests that mechanisms associated with ovarian dysfunction can be improved by exercise in PCOS.
引用
收藏
页码:977 / 979
页数:3
相关论文
共 50 条
  • [41] Clinical significance of serum concentration of anti-Mullerian hormone in obese women with polycystic ovary syndrome
    El-Halawaty, Samir
    Rizk, Ahmed
    Kamal, Manal
    AboulHassan, Mona
    Al-Sawah, Heba
    Noah, Olfat
    Al-Inany, Hesham
    REPRODUCTIVE BIOMEDICINE ONLINE, 2007, 15 (05) : 495 - 499
  • [42] Anti-Mullerian hormone: plasma levels in women with polycystic ovary syndrome and with premature ovarian failure
    Skalba, Piotr
    Cygal, Anna
    MENOPAUSE REVIEW-PRZEGLAD MENOPAUZALNY, 2011, 10 (03): : 232 - 236
  • [43] Longitudinal Anti-Mullerian Hormone in Women with Polycystic Ovary Syndrome: An Acupuncture Randomized Clinical Trial
    Franasiak, Jason
    Young, Steven L.
    Williams, Christopher D.
    Pastore, Lisa M.
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2012, 2012
  • [44] The effect of weight loss program on serum anti-Mullerian hormone level in obese and overweight infertile women with polycystic ovary syndrome
    Moini, Ashraf
    Arabipoor, Arezoo
    Hemat, Mandana
    Ahmadi, Jila
    Salman-Yazdi, Reza
    Zolfaghari, Zahra
    GYNECOLOGICAL ENDOCRINOLOGY, 2019, 35 (02) : 119 - 123
  • [45] The impact of laparoscopic ovarian drilling in patients with anovulatory polycystic ovary syndrome and high serum levels of Anti-Mullerian Hormone
    Mohammad, Shiemaa Mohsen
    JOURNAL OF POPULATION THERAPEUTICS AND CLINICAL PHARMACOLOGY, 2023, 30 (02): : E131 - E136
  • [46] Serum anti-Mullerian hormone concentrations reflect the presence of symptoms in women with polycystic ovary syndrome
    Homburg, R.
    Ray, A.
    Bhide, P.
    Gudi, A.
    Shah, A.
    Timms, P.
    Grayson, K.
    HUMAN REPRODUCTION, 2013, 28 : 7 - 7
  • [47] Determination of Ovarian Reserve with Anti-Mullerian Hormone in Patients with Polycystic Ovary Syndrome and Premenopausal Women
    Inan, Cihan
    Yucel, Nese
    Isbilen, Banu
    Isman, Kemal Ferruh
    Bilgic, Ergun
    Ozer, Atinc
    JOURNAL OF ACADEMIC RESEARCH IN MEDICINE-JAREM, 2014, 4 (02): : 62 - 68
  • [48] Assessment of Anti-Mullerian Hormone Level in Management of Adolescents with Polycystic Ovary Syndrome
    Dursun, Fatma
    Guven, Ayla
    Yildiz, Metin
    JOURNAL OF CLINICAL RESEARCH IN PEDIATRIC ENDOCRINOLOGY, 2016, 8 (01) : 55 - 60
  • [49] Anti-Mullerian hormone (AMH) as a useful marker in diagnosis of polycystic ovary syndrome
    Leonte, Laura
    Coculescu, M.
    Radian, S.
    Fica, Simona
    Caragheorgheopol, Andra
    Marinescu, B.
    Bohaltea, L. C.
    Grigorescu, F.
    ACTA ENDOCRINOLOGICA-BUCHAREST, 2007, 3 (01) : 1 - 11
  • [50] Serum anti-mullerian hormone levels in the main phenotypes of polycystic ovary syndrome
    Sahmay, Sezai
    Atakul, Nil
    Oncul, Mahmut
    Tuten, Abdullah
    Aydogan, Begum
    Seyisoglu, Hakan
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2013, 170 (01) : 157 - 161